USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND

The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated sk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAN, Mo, QIN, Ning, ZHANG, Hancheng, LIU, Xibao, LYU, Lu, LIU, Jieru, ZHANG, Dandan, CAI, Congcong, YANG, Hanyu
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DAN, Mo
QIN, Ning
ZHANG, Hancheng
LIU, Xibao
LYU, Lu
LIU, Jieru
ZHANG, Dandan
CAI, Congcong
YANG, Hanyu
description The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022234495A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022234495A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022234495A13</originalsourceid><addsrcrecordid>eNrjZNAPDXZV8HdTCAnydI509vF0VvBwDXEN8ncMivTRdfb3C3H09PP0c1dw9vcN8A_1c-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGOoUYGRkZGxiYmlqaOhsbEqQIAsq8nCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><source>esp@cenet</source><creator>DAN, Mo ; QIN, Ning ; ZHANG, Hancheng ; LIU, Xibao ; LYU, Lu ; LIU, Jieru ; ZHANG, Dandan ; CAI, Congcong ; YANG, Hanyu</creator><creatorcontrib>DAN, Mo ; QIN, Ning ; ZHANG, Hancheng ; LIU, Xibao ; LYU, Lu ; LIU, Jieru ; ZHANG, Dandan ; CAI, Congcong ; YANG, Hanyu</creatorcontrib><description>The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240627&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022234495A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25553,76306</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240627&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022234495A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAN, Mo</creatorcontrib><creatorcontrib>QIN, Ning</creatorcontrib><creatorcontrib>ZHANG, Hancheng</creatorcontrib><creatorcontrib>LIU, Xibao</creatorcontrib><creatorcontrib>LYU, Lu</creatorcontrib><creatorcontrib>LIU, Jieru</creatorcontrib><creatorcontrib>ZHANG, Dandan</creatorcontrib><creatorcontrib>CAI, Congcong</creatorcontrib><creatorcontrib>YANG, Hanyu</creatorcontrib><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><description>The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPDXZV8HdTCAnydI509vF0VvBwDXEN8ncMivTRdfb3C3H09PP0c1dw9vcN8A_1c-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGOoUYGRkZGxiYmlqaOhsbEqQIAsq8nCw</recordid><startdate>20240627</startdate><enddate>20240627</enddate><creator>DAN, Mo</creator><creator>QIN, Ning</creator><creator>ZHANG, Hancheng</creator><creator>LIU, Xibao</creator><creator>LYU, Lu</creator><creator>LIU, Jieru</creator><creator>ZHANG, Dandan</creator><creator>CAI, Congcong</creator><creator>YANG, Hanyu</creator><scope>EVB</scope></search><sort><creationdate>20240627</creationdate><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><author>DAN, Mo ; QIN, Ning ; ZHANG, Hancheng ; LIU, Xibao ; LYU, Lu ; LIU, Jieru ; ZHANG, Dandan ; CAI, Congcong ; YANG, Hanyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022234495A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAN, Mo</creatorcontrib><creatorcontrib>QIN, Ning</creatorcontrib><creatorcontrib>ZHANG, Hancheng</creatorcontrib><creatorcontrib>LIU, Xibao</creatorcontrib><creatorcontrib>LYU, Lu</creatorcontrib><creatorcontrib>LIU, Jieru</creatorcontrib><creatorcontrib>ZHANG, Dandan</creatorcontrib><creatorcontrib>CAI, Congcong</creatorcontrib><creatorcontrib>YANG, Hanyu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAN, Mo</au><au>QIN, Ning</au><au>ZHANG, Hancheng</au><au>LIU, Xibao</au><au>LYU, Lu</au><au>LIU, Jieru</au><au>ZHANG, Dandan</au><au>CAI, Congcong</au><au>YANG, Hanyu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><date>2024-06-27</date><risdate>2024</risdate><abstract>The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2022234495A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T08%3A50%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAN,%20Mo&rft.date=2024-06-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022234495A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true